Cargando…
HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1
Temozolomide (TMZ) is an alkylating agent chemotherapy drug used as a first-line treatment for glioblastoma multiforme (GBM). O(6)-methyl-guanine DNA methyltransferase (MGMT) repairs DNA damage induced by TMZ; hence, elevated MGMT levels usually correlate with TMZ resistance. MGMT promoter methylati...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872666/ https://www.ncbi.nlm.nih.gov/pubmed/31798765 http://dx.doi.org/10.18632/genesandcancer.197 |